May 9, 2022
Roughly 87,000 COVID-19 patients had received MSD’s oral pill Lagevrio (molnupiravir) through registered pharmacies in Japan as of April 15, according to the Japan Pharmaceutical Association (JPA). As of that date, around 20,000 pharmacies were registered for handling the drug,...read more